Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with moderate-to-severe atopic dermatitis (a significant form of eczema), confirmed by a specific score above 24 on a standard skin assessment scale
- You are currently receiving, or have previously received, a systemic treatment (a medication that works throughout the whole body) for your eczema, such as a biologic drug or a small molecule drug
- If your data is being used from past records, there must be at least one follow-up appointment on record after your treatment started, with health and personal information collected both at the start and during follow-up visits
- You are willing to sign a consent form agreeing to take part in the study and to allow your personal data to be used for research
Who may not be able to join:
- You are under 18 years of age
- You have received a systemic biologic or small molecule treatment, but the date your treatment started is not known, or no health and personal information was recorded at the start of treatment or at follow-up visits
- You are not willing to sign a consent form allowing your data to be used for research purposes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ketty Peris, Prof, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630155284
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
drug survival evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.